fluorine-18-labelled peptides (Immunomedics)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namefluorine-18-labelled peptides (Immunomedics)

Drug Alias Name18F IMP-468F-18-labelled IMP-468 (Immunomedics)F-18-labelled bombesin peptide (Immunomedics)IMP-467 (Immunomedics)IMP-468 (Immunomedics) +[12]

ClassificationBiologics > Protein drugs > Recombinant polypeptideDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agent

Mechanisms of ActionPositron-emission tomography enhancers

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesImmunomedics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesImmunomedics Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A